Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research – Diabetes and Obesity

Volume 1

Personal Book: US $79 Special Offer (PDF + Printed Copy): US $158
Printed Copy: US $119
Library Book: US $316
ISSN: 2467-9607
eISSN: 2352-3220 (Online)
ISBN: 978-1-60805-857-0
eISBN: 978-1-60805-856-3 (Online)
Year of Publication: 2014
DOI: 10.2174/97816080585631140101

Introduction

Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.

The first volume of this series features 6 chapters that cover a variety of topics including:

  • - Angiotensin blockers
  • - Agents targeting advanced glycation end products
  • - Drugs and the peroxisome proliferator activated receptors
  • - Topical Drugs for diabetic complications
  • - Research on Liraglutide
  • - Research on MicroRNAs as agents for diabetes treatment

Contributors

Editor(s):
Prof. Dr. Atta-ur-Rahman
Kings College University of Cambridge
Cambridge
UK




Contributor(s):
Agustin Busta
Division of Endocrinology, Department of Medicine
Beth Israel Medical Center and Albert Einstein College of Medicine
New York
NY, 10003
USA


Andrew Hartland
Consultant Chemical Pathologist
Walsall Manor Hospital
UK


Ashutosh Pareek
Division of Endocrinology, Department of Medicine
Beth Israel Medical Center and Albert Einstein College of Medicine
New York
NY, 10003
USA


Cornelia Zetu
National Institute of Diabetes
Nutrition and Metabolic Diseases “N.C. Paulescu”
Bucharest
Romania


Cristian Serafinceanu
National Institute of Diabetes
Nutrition and Metabolic Diseases “N.C. Paulescu”
Bucharest
Romania


Dan Mircea Cheţa
National Institute of Diabetes
Nutrition and Metabolic Diseases “N.C. Paulescu”
Bucharest
Romania


Emilia Liao
Division of Endocrinology, Department of Medicine
Beth Israel Medical Center and Albert Einstein College of Medicine
New York
NY, 10003
USA


Kevin Stuart
Specialist Registrar in Chemical Pathology/Metabolic Medicine
Heart of England Foundation Trust
UK


Leonid Poretsky
Division of Endocrinology, Department of Medicine
Beth Israel Medical Center and Albert Einstein College of Medicine
New York
NY, 10003
USA


Macaulay A.C. Onuigbo
College of Medicine
Mayo Clinic
Rochester
MN

/
Luther Midelfort Site, Mayo Health System Practice-Based Research Network (MHS PBRN), Department of Nephrology
Mayo Clinic Health System Eau Claire
1221 Whipple Street, Eau Claire
WI, 54702
USA


Mithun Bhartia
Specialist Registrar in Diabetes and Endocrinology
Sandwell Hospital, West Birmingham NHS Trust
UK


Puneetpal Singh
Department of Human Genetics
Punjabi University
Patiala, Punjab
India


Ryuhei Sano Central
Pharmaceutical Research Institute
Japan Tobacco Inc
Takatsuki Osaka, 569- 1125
Japan


Sudarshan Ramachandran
Department of Clinical Biochemistry
Good Hope Hospital, Heart of England NHS Foundation Trust
Rectory Road, Sutton Coldfield
West Midlands
United Kingdom


Tomohiko Sasase
Central Pharmaceutical Research Institute
Japan Tobacco Inc
Takatsuki, Osaka
Japan




RELATED BOOKS

.Phytotherapy in the Management of Diabetes and Hypertension.
.Frontiers in Clinical Drug Research – Diabetes and Obesity.
.Understanding Obesity: From its Causes to Impact on Life.
.Epidemiology of Type 2 Diabetes.